Jynarque for patient T.H.
Ended Awarded
- Contract number
- 36C24621F0035
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,099
Award facts
- Contract value 100% obligated
- $10,099.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Richmond, VA 23249, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a delivery order to Otsuka America Pharmaceutical Inc. on October 7, 2020, for the supply of Jynarque (tolvaptan) pharmaceutical product for patient treatment at a firm-fixed price of $10,099.21. This delivery order was issued without a set-aside designation and represents performance in Richmond, Virginia, with an ultimate completion date of October 8, 2020. Jynarque is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia, conditions requiring specialized medical management within the Veterans Health Administration.
This delivery order was issued under Otsuka America Pharmaceutical Inc.'s larger Indefinite Delivery Vehicle—a blanket purchase agreement valued at $83.3 million for Jynarque awarded by the National Acquisition Center through the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The company, headquartered in Rockville, Maryland, is an established federal contractor providing critical specialty pharmaceuticals to VA Integrated Service Networks across the country. The blanket purchase agreement, which extends through March 26, 2026, enables VA medical facilities to efficiently procure this specialized medication to support comprehensive healthcare services for veterans nationwide.
Quick answers
Who was awarded contract 36C24621F0035?
36C24621F0035 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on October 7, 2020.
How much is contract 36C24621F0035 worth?
The government has obligated $10,099 on 36C24621F0035.
Is contract 36C24621F0035 an order under another contract?
Yes. 36C24621F0035 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24621F0035 competed?
The extent of competition for 36C24621F0035 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award